Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Dermata Therapeutics Inc | DRMA | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,33725 | 0,33 | 0,355 | 0,336 | 0,3401 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
12.1.2024 | 22:06 | EDGAR2 | Form 8-K - Current report |
06.1.2024 | 03:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
06.1.2024 | 03:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
06.1.2024 | 03:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18.12.2023 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
15.12.2023 | 23:00 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
07.12.2023 | 22:05 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
09.11.2023 | 22:09 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09.11.2023 | 22:08 | EDGAR2 | Form 8-K - Current report |
10.8.2023 | 22:18 | EDGAR2 | Form 8-K - Current report |
10.8.2023 | 22:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
03.8.2023 | 22:31 | EDGAR2 | Form 8-K - Current report |